Human Investing’s Alexion Pharmaceuticals ALXN Stock Holding History

Human Investing’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-20	Closed	-$3K	–	308
2021 Q1	$3K	Hold	20	–	–	﹤0.01%	275
2020 Q4	$3K	Hold	20	–	–	﹤0.01%	273
2020 Q3	$2K	Hold	20	–	–	﹤0.01%	283
2020 Q2	$2K	Hold	20	–	–	﹤0.01%	291
2020 Q1	$2K	Hold	20	–	–	﹤0.01%	284
2019 Q4	$2K	Hold	20	–	–	﹤0.01%	345
2019 Q3	$2K	Hold	20	–	–	﹤0.01%	333
2019 Q2	$3K	Hold	20	–	–	﹤0.01%	321
2019 Q1	$3K	Sell	20 -7	-26%	-$870	﹤0.01%	303
2018 Q4	$3K	Buy	+27	New	+$3.19K	﹤0.01%	336

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Human Investing's ALXN Position: Q2 2021 in Review

Human Investing sold out of Alexion Pharmaceuticals (ALXN) in Q2 2021, closing a stake of 20 shares — an estimated $3K sold.

Human Investing first reported a position in ALXN in Q4 2018 and held it in 10 quarters. The position peaked at $3K in Q1 2021. 710 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

Human Investing reported no remaining Alexion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Human Investing sold 20 Alexion Pharmaceuticals shares in Q2 2021, an estimated $3K.
Human Investing first reported a position in Alexion Pharmaceuticals in Q4 2018 and held it in 10 quarters.
Human Investing's Alexion Pharmaceuticals position peaked at $3K in Q1 2021.
710 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on Human Investing's 13F filing for Q2 2021, filed 2 Aug 2021.